Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
HumanPheno	Disseminated intravascular coagulation	CFH IRF2BP2 OBSCN LPIN1 NFS1 PRKAR1A	8.81e-06	29	90	6	HP:0005521
HumanPheno	Tracheomalacia	RALGAPA1 USP9X CHD6 FGFR2 POLR1A EHMT1 PAX3	2.00e-05	49	90	7	HP:0002779
HumanPheno	Abnormal tracheal morphology	RALGAPA1 USP9X FREM2 CHD6 FGFR2 FRAS1 POLR1A POLA1 RET EHMT1 PAX3 ADAMTSL2	3.68e-05	170	90	12	HP:0002778
Domain	PAX	PAX1 PAX3 PAX7 PAX9	3.63e-06	9	248	4	SM00351
Domain	PAIRED_2	PAX1 PAX3 PAX7 PAX9	3.63e-06	9	248	4	PS51057
Domain	PAIRED_1	PAX1 PAX3 PAX7 PAX9	3.63e-06	9	248	4	PS00034
Domain	Paired_dom	PAX1 PAX3 PAX7 PAX9	3.63e-06	9	248	4	IPR001523
Domain	PAX	PAX1 PAX3 PAX7 PAX9	3.63e-06	9	248	4	PF00292
Domain	ARM-type_fold	DCAF1 RALGAPA1 NBEAL1 USP9X IFT172 PIK3C2G DIAPH1 MROH7 EIF3K COPB1 USP24 FHOD3 UNC45B MROH2B CTNND1	5.09e-05	339	248	15	IPR016024
Domain	DNA/RNA_helicase_DEAH_CS	DHX33 RECQL5 CHD6 DHX16 CHD8	9.29e-05	35	248	5	IPR002464
Domain	DEAH_ATP_HELICASE	DHX33 RECQL5 CHD6 DHX16 CHD8	1.39e-04	38	248	5	PS00690
Domain	Pax7_C	PAX3 PAX7	1.76e-04	2	248	2	IPR022106
Domain	2-oxogl_dehyd_N	OGDH OGDHL	1.76e-04	2	248	2	IPR032106
Domain	Pax7	PAX3 PAX7	1.76e-04	2	248	2	PF12360
Domain	2-oxogl_dehyd_N	OGDH OGDHL	1.76e-04	2	248	2	PF16078
Domain	K_chnl_volt-dep_EAG	KCNH1 KCNH5	1.76e-04	2	248	2	IPR003949
Domain	PAS_9	KCNH7 KCNH1 KCNH5	2.59e-04	10	248	3	PF13426
Domain	GFP-like	SVEP1 ADGRL4 HMCN1	3.53e-04	11	248	3	IPR023413
Domain	-	SVEP1 ADGRL4 HMCN1	3.53e-04	11	248	3	2.40.155.10
Domain	2oxoglutarate_DH_E1	OGDH OGDHL	5.22e-04	3	248	2	IPR011603
Domain	KGD_C	OGDH OGDHL	5.22e-04	3	248	2	IPR031717
Domain	OxoGdeHyase_C	OGDH OGDHL	5.22e-04	3	248	2	PF16870
Domain	Helicase_C	DHX33 ZRANB3 RECQL5 CHD6 DDX60L DHX16 CHD8	5.65e-04	107	248	7	PF00271
Domain	HELICc	DHX33 ZRANB3 RECQL5 CHD6 DDX60L DHX16 CHD8	5.65e-04	107	248	7	SM00490
Domain	Helicase_C	DHX33 ZRANB3 RECQL5 CHD6 DDX60L DHX16 CHD8	5.97e-04	108	248	7	IPR001650
Domain	HELICASE_CTER	DHX33 ZRANB3 RECQL5 CHD6 DDX60L DHX16 CHD8	6.31e-04	109	248	7	PS51194
Domain	HELICASE_ATP_BIND_1	DHX33 ZRANB3 RECQL5 CHD6 DDX60L DHX16 CHD8	6.31e-04	109	248	7	PS51192
Domain	DEXDc	DHX33 ZRANB3 RECQL5 CHD6 DDX60L DHX16 CHD8	6.31e-04	109	248	7	SM00487
Domain	Helicase_ATP-bd	DHX33 ZRANB3 RECQL5 CHD6 DDX60L DHX16 CHD8	6.67e-04	110	248	7	IPR014001
Domain	K_chnl_volt-dep_EAG/ELK/ERG	KCNH7 KCNH1 KCNH5	7.56e-04	14	248	3	IPR003938
Domain	CNMP_BINDING_1	KCNH7 KCNH1 PRKAR1A KCNH5	8.15e-04	32	248	4	PS00888
Domain	CNMP_BINDING_2	KCNH7 KCNH1 PRKAR1A KCNH5	8.15e-04	32	248	4	PS00889
Domain	Ig_I-set	PRTG OBSCN PTPRK FGFR2 FGFR4 CNTN1 DSCAM HMCN1 ALPK2	1.02e-03	190	248	9	IPR013098
Domain	I-set	PRTG OBSCN PTPRK FGFR2 FGFR4 CNTN1 DSCAM HMCN1 ALPK2	1.02e-03	190	248	9	PF07679
Domain	cNMP	KCNH7 KCNH1 PRKAR1A KCNH5	1.03e-03	34	248	4	SM00100
Domain	cNMP_binding	KCNH7 KCNH1 PRKAR1A KCNH5	1.03e-03	34	248	4	PF00027
Domain	Argonaute_N	AGO4 AGO1	1.04e-03	4	248	2	IPR032474
Domain	Argonaute_Mid_dom	AGO4 AGO1	1.04e-03	4	248	2	IPR032473
Domain	ArgoL2	AGO4 AGO1	1.04e-03	4	248	2	IPR032472
Domain	FGF_rcpt_fam	FGFR2 FGFR4	1.04e-03	4	248	2	IPR016248
Domain	ArgoN	AGO4 AGO1	1.04e-03	4	248	2	PF16486
Domain	ArgoMid	AGO4 AGO1	1.04e-03	4	248	2	PF16487
Domain	ArgoL2	AGO4 AGO1	1.04e-03	4	248	2	PF16488
Domain	cNMP-bd_dom	KCNH7 KCNH1 PRKAR1A KCNH5	1.15e-03	35	248	4	IPR000595
Domain	CNMP_BINDING_3	KCNH7 KCNH1 PRKAR1A KCNH5	1.15e-03	35	248	4	PS50042
Domain	IGc2	PRTG PSG5 OBSCN FGFR2 FGFR4 CNTN1 DSCAM HMCN1 FCRL5 ALPK2	1.23e-03	235	248	10	SM00408
Domain	Ig_sub2	PRTG PSG5 OBSCN FGFR2 FGFR4 CNTN1 DSCAM HMCN1 FCRL5 ALPK2	1.23e-03	235	248	10	IPR003598
Domain	IG	PRTG PSG5 OBSCN PTPRK FGFR2 FGFR4 CNTN1 DSCAM MPIG6B HMCN1 FCRL5 IL1RAP IGSF21 ALPK2	1.56e-03	421	248	14	SM00409
Domain	Ig_sub	PRTG PSG5 OBSCN PTPRK FGFR2 FGFR4 CNTN1 DSCAM MPIG6B HMCN1 FCRL5 IL1RAP IGSF21 ALPK2	1.56e-03	421	248	14	IPR003599
Domain	cNMP-bd-like	KCNH7 KCNH1 PRKAR1A KCNH5	1.57e-03	38	248	4	IPR018490
Domain	Biotin_BS	MCCC1 PC	1.71e-03	5	248	2	IPR001882
Domain	GST_mu	GSTM2 GSTM5	1.71e-03	5	248	2	IPR003081
Domain	Biotin_COase_C	MCCC1 PC	1.71e-03	5	248	2	IPR005482
Domain	BC	MCCC1 PC	1.71e-03	5	248	2	PS50979
Domain	Biotin_carb_C	MCCC1 PC	1.71e-03	5	248	2	SM00878
Domain	Biotin_carb_C	MCCC1 PC	1.71e-03	5	248	2	PF02785
Domain	Biotin_carboxylation_dom	MCCC1 PC	1.71e-03	5	248	2	IPR011764
Domain	DUF1785	AGO4 AGO1	1.71e-03	5	248	2	SM01163
Domain	BIOTIN	MCCC1 PC	1.71e-03	5	248	2	PS00188
Pathway	REACTOME_RHO_GTPASE_CYCLE	RALGAPA1 FILIP1 MYO9A USP9X OBSCN FRS2 NDUFA5 PIK3R2 DIAPH1 CDC42BPA ARHGAP23 DSP PREX2 RHOG ARHGDIG ARAP3 WDR11 GOLGA8B GOLGA8A SPATA13	8.48e-07	439	180	20	MM15595
Pathway	REACTOME_RHO_GTPASE_CYCLE	RALGAPA1 FILIP1 LEMD3 MYO9A USP9X OBSCN FRS2 NDUFA5 PIK3R2 DIAPH1 CDC42BPA ARHGAP23 DSP PREX2 RHOG ARHGDIG ARAP3 WDR11 SPATA13	4.93e-06	450	180	19	M27078
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	CBLL1 USP9X IQSEC2 ADGRB3 DDN BTBD9 CNTNAP5 DIAPH1 HERC2 NOS1 CNTN1 CARM1 DSCAM CAMK2B SYNE1 MSANTD2 CHD8 AGO1 PDE4DIP EHMT1 PRKAR1A GOLGA8B MAPK1 CTNND1 GOLGA8A SPATA13	9.85e-09	963	251	26	28671696
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	CFH PRSS3 USP9X IFT172 SPTB IQSEC2 PEG3 USP25 ADGRB3 LRP1B PTPRK NR1H2 CHD6 HERC2 QARS1 COG2 RAP1GAP DSCAM COPB1 DSP SYNE1 CTDSP1 ZNF181 CNPPD1 RHOG TMEM168 PDE4DIP PRKAR1A PC ZNF292	1.82e-08	1285	251	30	35914814
Pubmed	Myogenic-specific ablation of Fgfr1 impairs FGF2-mediated proliferation of satellite cells at the myofiber niche but does not abolish the capacity for muscle regeneration.	ITGA7 FGFR2 FGFR4 PAX7	1.81e-07	8	251	4	26074812
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	PPP2R2D CLK4 AGO4 PIK3R2 EIF3K DDX60L FGFR2 FGFR4 CARM1 UNC119B CDC42BPA POLR1A ARHGAP23 CAMK2B RET NFS1 AGO1 UTP25 PDE4DIP PRKAR1A MAPK1 CTNND1 EXOSC7	2.36e-07	910	251	23	36736316
Pubmed	Pax genes and their role in organogenesis.	PAX1 PAX3 PAX7 PAX9	3.24e-07	9	251	4	10197584
Pubmed	Pax3 regulation of FGF signaling affects the progression of embryonic progenitor cells into the myogenic program.	FGFR4 PAX3 PAX7 MAPK1	3.24e-07	9	251	4	18593883
Pubmed	Pax genes in development.	PAX1 PAX3 PAX7 PAX9	3.24e-07	9	251	4	7883790
Pubmed	Chromosomal localization of seven PAX genes and cloning of a novel family member, PAX-9.	PAX1 PAX3 PAX7 PAX9	3.24e-07	9	251	4	7981748
Pubmed	Conservation of the paired domain in metazoans and its structure in three isolated human genes.	PAX1 PAX3 PAX7	3.71e-07	3	251	3	2501086
Pubmed	Requirement of the paraxis gene for somite formation and musculoskeletal patterning.	PAX1 PAX3 PAX7 PAX9	5.38e-07	10	251	4	8955271
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	DCAF1 MYO9A PSMC5 PFAS DHX33 MCCC1 RECQL5 DIAPH1 DDX60L HERC2 QARS1 DHX16 RANBP1 POLR1A COPB1 ARHGAP23 DSP POLA1 PTPN23 CHD8 ATAD2 TOE1 RHOG ARAP3 LLGL1 WDR11 MAPK1 CTNND1	6.43e-07	1353	251	28	29467282
Pubmed	Pax3 Hypomorphs Reveal Hidden Pax7 Functional Genetic Compensation in Utero.	PAX1 PAX3 PAX7 PAX9	8.40e-07	11	251	4	35645295
Pubmed	Maternal transmission effects of the PAX genes among cleft case-parent trios from four populations.	PAX3 PAX7 PAX9	1.48e-06	4	251	3	19142206
Pubmed	Amplification of FRS2 and activation of FGFR/FRS2 signaling pathway in high-grade liposarcoma.	FRS2 FGFR2 FGFR4	1.48e-06	4	251	3	23393200
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DCAF1 IFT172 PEG3 DDN KANK1 CHD6 DHX16 FRAS1 DNAJC16 SYNE1 ZHX2 PDE4DIP SPATA13 PLCE1	1.84e-06	407	251	14	12693553
Pubmed	CLEC16A interacts with retromer and TRIM27, and its loss impairs endosomal trafficking and neurodevelopment.	PPP2R2D PFAS NDUFA5 PARP4 HERC2 DHX16 EXOC6 COG2 COPB1 SZT2 DNAJC16 CAMK2B ORC5 DCAF10 WDR11 CTNND1 PC	2.36e-06	606	251	17	36538041
Pubmed	The concerted action of Meox homeobox genes is required upstream of genetic pathways essential for the formation, patterning and differentiation of somites.	PAX1 PAX3 PAX7 PAX9	3.40e-06	15	251	4	12925591
Pubmed	SRY interference of normal regulation of the RET gene suggests a potential role of the Y-chromosome gene in sexual dimorphism in Hirschsprung disease.	SRY RET PAX3	3.67e-06	5	251	3	25267720
Pubmed	In vivo dissection of a clustered-CTCF domain boundary reveals developmental principles of regulatory insulation.	FGFR2 WDR11 PAX3	3.67e-06	5	251	3	35817979
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	SPTB PEG3 OBSCN NEB PARP4 PDLIM3 UBE2E3 CDC42BPA DSP SYNE1 ZNF181 PDE4DIP PRKAR1A PAX7 PLCE1	3.90e-06	497	251	15	23414517
Pubmed	Transcription factors Mesp2 and Paraxis have critical roles in axial musculoskeletal formation.	PAX1 PAX3 PAX7 PAX9	4.50e-06	16	251	4	17477400
Pubmed	Frs2α enhances fibroblast growth factor-mediated survival and differentiation in lens development.	FRS2 FGFR2 RET MAPK1	5.85e-06	17	251	4	23136392
Pubmed	Molecular genetics of the Pax gene family.	PAX1 PAX3 PAX7	7.31e-06	6	251	3	1485966
Pubmed	Notochord-dependent expression of MFH1 and PAX1 cooperates to maintain the proliferation of sclerotome cells during the vertebral column development.	PAX1 PAX3 PAX9	7.31e-06	6	251	3	10364424
Pubmed	Independent roles of Fgfr2 and Frs2alpha in ureteric epithelium.	FRS2 FGFR2 RET	7.31e-06	6	251	3	21350013
Pubmed	Trans-activation of EphA4 and FGF receptors mediated by direct interactions between their cytoplasmic domains.	FRS2 FGFR2 FGFR4	7.31e-06	6	251	3	16365308
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	KCNH7 REEP1 BCAS3 USP9X IQSEC2 ADGRB3 MCCC1 NDUFA5 LRP1B NOS1 RPS4Y2 CDC42BPA DSP DNAJC16 CAMK2B USP24 NFS1 OGDH PDE4DIP PRKAR1A UBR3 CTNND1 PC	1.01e-05	1139	251	23	36417873
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	RALGAPA1 MYO9A BCAS3 TTC21A SPTB OBSCN BTBD9 SYNJ2 CHD6 ZSWIM4 UBE2E3 CDC42BPA POLR1A NRF1 MAN1C1 CAMK2B ZHX2 WDR37 OGDH HPS3 WDR11 GUCY1A1 PCNX4 EHMT1 ZFHX2 CTNND1 HPS5	1.17e-05	1489	251	27	28611215
Pubmed	Redox regulation by Pitx2 and Pitx3 is critical for fetal myogenesis.	NRF1 PAX3 PAX7	1.27e-05	7	251	3	24871946
Pubmed	RhoGDI-3 is a new GDP dissociation inhibitor (GDI). Identification of a non-cytosolic GDI protein interacting with the small GTP-binding proteins RhoB and RhoG.	ZHX2 RHOG ARHGDIG	1.27e-05	7	251	3	8939998
Pubmed	Cellular taxonomy of Hic1+ mesenchymal progenitor derivatives in the limb: from embryo to adult.	PAX1 PAX3 PAX7	1.27e-05	7	251	3	36008423
Pubmed	Exome sequencing reveals pathogenic mutations in 91 strains of mice with Mendelian disorders.	PFAS OTOP3 FREM2 CNTN1 DSP PAX3	1.40e-05	72	251	6	25917818
Pubmed	Long-term potentiation modulates synaptic phosphorylation networks and reshapes the structure of the postsynaptic interactome.	IQSEC2 ADGRB3 DDN BTBD9 DIAPH1 CNTN1 CAMK2B SYNE1 MAPK1 CTNND1	1.60e-05	251	251	10	27507650
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	RALGAPA1 MYO9A BCAS3 USP9X TTC21A SPTB IQSEC2 GABARAPL2 NOS1 CNTN1 RPS4Y2 RAP1GAP COPB1 ARHGAP23 DSP CAMK2B SYNE1 WDR37 OGDH AGO1 PDE4DIP PRKAR1A OGDHL MAPK1 CTNND1 PC	1.66e-05	1431	251	26	37142655
Pubmed	The function of FGF signaling in the lens placode.	FRS2 FGFR2 FGFR4 MAPK1	2.11e-05	23	251	4	21223962
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	C12orf56 PFAS LPIN1 FREM2 PARP4 DHX16 FRAS1 RAP1GAP ARHGAP23 DNAJC16 CHD8 ARAP3 LLGL1 WDR11 HPS5 PLCE1	2.35e-05	650	251	16	38777146
Pubmed	Expression of the immunoglobulin superfamily cell adhesion molecules in the developing spinal cord and dorsal root ganglion.	PRTG PSG5 OBSCN PTPRK CNTN1 DSCAM HMCN1 IL1RAP	2.50e-05	162	251	8	25826454
Pubmed	Functional proteomics mapping of a human signaling pathway.	LEMD3 PSG5 USP25 SVEP1 KANK1 DIAPH1 CHD6 HERC2 QARS1 THSD7A MAN1C1 PDE4DIP PAXIP1 PRKAR1A IL1RAP	2.98e-05	591	251	15	15231748
Pubmed	Uncommitted precursor cells might contribute to increased incidence of embryonal rhabdomyosarcoma in heterozygous Patched1-mutant mice.	ITGA7 PAX3 PAX7	3.02e-05	9	251	3	21602886
Pubmed	Deletion of Frs2alpha from the ureteric epithelium causes renal hypoplasia.	FRS2 FGFR2 RET	3.02e-05	9	251	3	19741018
Pubmed	Severe defects in the formation of epaxial musculature in open brain (opb) mutant mouse embryos.	PAX1 PAX3 PAX9	3.02e-05	9	251	3	8565855
Pubmed	Bapx1: an evolutionary conserved homologue of the Drosophila bagpipe homeobox gene is expressed in splanchnic mesoderm and the embryonic skeleton.	PAX1 PAX3 PAX7	3.02e-05	9	251	3	9256352
Pubmed	Stimulation of phosphatidylinositol 3-kinase by fibroblast growth factor receptors is mediated by coordinated recruitment of multiple docking proteins.	FRS2 PIK3R2 FGFR2	3.02e-05	9	251	3	11353842
Pubmed	Dusp6 (Mkp3) is a negative feedback regulator of FGF-stimulated ERK signaling during mouse development.	FGFR2 FGFR4 MAPK1	3.02e-05	9	251	3	17164422
Pubmed	Development of the thymus requires signaling through the fibroblast growth factor receptor R2-IIIb.	FGFR2 PAX1 PAX9	3.02e-05	9	251	3	11489975
Pubmed	Pax3:Fkhr interferes with embryonic Pax3 and Pax7 function: implications for alveolar rhabdomyosarcoma cell of origin.	PAX3 PAX7 PAX9	3.02e-05	9	251	3	15520281
Pubmed	Interactions of the Antiviral Factor Interferon Gamma-Inducible Protein 16 (IFI16) Mediate Immune Signaling and Herpes Simplex Virus-1 Immunosuppression.	DHX33 EIF3K DDX60L DHX16 CARM1 SYNE1 ATAD2 FCF1 PRKAR1A CTNND1 EXOSC7	3.33e-05	332	251	11	25693804
Pubmed	Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome.	EPPK1 FREM2 NELFE FRAS1 POLR1A DSP CHD8 ATAD2 OGDH	3.34e-05	219	251	9	31353912
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	RALGAPA1 PPP2R2D ADGRB3 FEM1C AGO4 SYNJ2 CDC42BPA SZT2 CHD8 WDR37 EHMT1 HPS5 EXOSC7 MINDY1	3.51e-05	529	251	14	14621295
Pubmed	Mouse screen reveals multiple new genes underlying mouse and human hearing loss.	CFH MYO9A DHX33 SYNJ2 PIK3R2 MROH7 LDLRAD4 PEAR1 NELFE COG2 NATD1 PRAMEF22 USP24 WDR37 OGDH MOSPD1 AGO1 MAPK1 PAX9 LRMDA MINDY1 ACTL10 RAPGEFL1	3.90e-05	1242	251	23	30973865
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	ADGRB3 CHD6 THSD7A DNAJC16 SYNE1 PTPN23 CHD8 EHMT1 HPS5	4.12e-05	225	251	9	12168954
Pubmed	Functional analysis of the SRY-KRAB interaction in mouse sex determination.	SRY ZNF729 ZNF99	4.29e-05	10	251	3	18588511
Pubmed	Bimodal regulation of an Elk subfamily K+ channel by phosphatidylinositol 4,5-bisphosphate.	KCNH7 KCNH1 KCNH5	4.29e-05	10	251	3	26503718
Pubmed	Interplays of Gli2 and Gli3 and their requirement in mediating Shh-dependent sclerotome induction.	PAX1 PAX3 PAX9	4.29e-05	10	251	3	14602680
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	PPP2R2D USP9X IFT172 ADGRB3 CHD6 HERC2 THSD7A ARHGAP23 DSP USP24 CHD8 PREX2 AGO1	4.75e-05	475	251	13	31040226
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	DCAF1 PPP2R2D USP25 PSMC5 PFAS DHX33 NDUFA5 BTBD9 FEM1C EIF3K HERC2 NELFE POLR1A POLA1 BAG5 OGDH LRR1 RRN3 ABCC12 CTNND1	4.76e-05	1005	251	20	19615732
Pubmed	Phospholipase Cε Modulates Rap1 Activity and the Endothelial Barrier.	RAP1GAP PLCE1	5.19e-05	2	251	2	27612188
Pubmed	House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells.	HLA-DQB2 TLR4	5.19e-05	2	251	2	19330007
Pubmed	The Importance of AGO 1 and 4 in Post-Transcriptional Gene Regulatory Function of tRF5-GluCTC, an Respiratory Syncytial Virus-Induced tRNA-Derived RNA Fragment.	AGO4 AGO1	5.19e-05	2	251	2	33233493
Pubmed	Sulfation of endothelial mucin by corneal keratan N-acetylglucosamine 6-O-sulfotransferase (GST-4beta).	CHST5 CHST6	5.19e-05	2	251	2	11352640
Pubmed	Matrix morphogenesis in cornea is mediated by the modification of keratan sulfate by GlcNAc 6-O-sulfotransferase.	CHST5 CHST6	5.19e-05	2	251	2	16938851
Pubmed	The DHX33 RNA helicase senses cytosolic RNA and activates the NLRP3 inflammasome.	DHX33 NLRP3	5.19e-05	2	251	2	23871209
Pubmed	Evolutionary conservation of gene structures of the Pax1/9 gene family.	PAX1 PAX9	5.19e-05	2	251	2	10899593
Pubmed	Mobilization of TLR4 Into Lipid Rafts by Aggregatibacter Actinomycetemcomitans in Gingival Epithelial Cells.	TLR4 MAPK1	5.19e-05	2	251	2	27744428
Pubmed	Alternate PAX3 and PAX7 C-terminal isoforms in myogenic differentiation and sarcomagenesis.	PAX3 PAX7	5.19e-05	2	251	2	21421465
Pubmed	ERK2 Phosphorylates PFAS to Mediate Posttranslational Control of De Novo Purine Synthesis.	PFAS MAPK1	5.19e-05	2	251	2	32485148
Pubmed	Human autoantibodies to a novel Golgi protein golgin-67: high similarity with golgin-95/gm 130 autoantigen.	GOLGA8B GOLGA8A	5.19e-05	2	251	2	10677249
Pubmed	An alternative splicing event in the Pax-3 paired domain identifies the linker region as a key determinant of paired domain DNA-binding activity.	PAX3 PAX7	5.19e-05	2	251	2	8943322
Pubmed	Cancer-associated fibroblasts expressing CXCL14 rely upon NOS1-derived nitric oxide signaling for their tumor-supporting properties.	NOS1 CXCL14	5.19e-05	2	251	2	24710408
Pubmed	Cell migration by a FRS2-adaptor dependent membrane relocation of ret receptors.	FRS2 RET	5.19e-05	2	251	2	18189271
Pubmed	Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A.	RET PRKAR1A	5.19e-05	2	251	2	7678053
Pubmed	Lactoferrin Retargets Human Adenoviruses to TLR4 to Induce an Abortive NLRP3-Associated Pyroptotic Response in Human Phagocytes.	NLRP3 TLR4	5.19e-05	2	251	2	34093588
Pubmed	Toll-like receptor 4-interacting SPA4 peptide suppresses the NLRP3 inflammasome in response to LPS and ATP stimuli.	NLRP3 TLR4	5.19e-05	2	251	2	26254306
Pubmed	Ethanol-Induced TLR4/NLRP3 Neuroinflammatory Response in Microglial Cells Promotes Leukocyte Infiltration Across the BBB.	NLRP3 TLR4	5.19e-05	2	251	2	26555554
Pubmed	Influence of sex chromosome constitution on the genomic imprinting of germ cells.	PEG3 SRY	5.19e-05	2	251	2	16847261
Pubmed	Protective role of p120-catenin on mitochondria by inhibiting NLRP3 in ventilator-induced lung injury.	NLRP3 CTNND1	5.19e-05	2	251	2	31507096
Pubmed	Chemopreventive effect of farnesol on DMBA/TPA-induced skin tumorigenesis: involvement of inflammation, Ras-ERK pathway and apoptosis.	ZHX2 MAPK1	5.19e-05	2	251	2	19470390
Pubmed	Alpinetin attenuates inflammatory responses by suppressing TLR4 and NLRP3 signaling pathways in DSS-induced acute colitis.	NLRP3 TLR4	5.19e-05	2	251	2	27321991
Pubmed	Activation of NLRP3 inflammasome by lymphocytic microparticles via TLR4 pathway contributes to airway inflammation.	NLRP3 TLR4	5.19e-05	2	251	2	31759058
Pubmed	The two mRNA forms for the type I alpha regulatory subunit of cAMP-dependent protein kinase from human testis are due to the use of different polyadenylation site signals.	RET PRKAR1A	5.19e-05	2	251	2	2310396
Pubmed	Comparison of the proximal promoter regions of the PAX3 and PAX7 genes.	PAX3 PAX7	5.19e-05	2	251	2	17954266
Pubmed	RhoGDI3 at the trans-Golgi network participates in NLRP3 inflammasome activation, VSMC phenotypic modulation, and neointima formation.	NLRP3 ARHGDIG	5.19e-05	2	251	2	38029612
Pubmed	Electron tomography reveals multiple self-association of chondroitin sulphate/dermatan sulphate proteoglycans in Chst5-null mouse corneas.	CHST5 CHST6	5.19e-05	2	251	2	21440637
Pubmed	Aberrant glycosaminoglycan biosynthesis by tumor suppressor EXTL2 deficiency promotes liver inflammation and tumorigenesis through Toll-like 4 receptor signaling.	EXTL2 TLR4	5.19e-05	2	251	2	32347583
Pubmed	Aberrant receptor internalization and enhanced FRS2-dependent signaling contribute to the transforming activity of the fibroblast growth factor receptor 2 IIIb C3 isoform.	FRS2 FGFR2	5.19e-05	2	251	2	19103595
Pubmed	Effects of Echinococcus multilocularis miR-71 mimics on murine macrophage RAW264.7 cells.	AGO4 AGO1	5.19e-05	2	251	2	26995025
Pubmed	A multigenic approach to evaluate genetic variants of PLCE1, LXRs, MMPs, TIMP, and CYP genes in gallbladder cancer predisposition.	NR1H2 PLCE1	5.19e-05	2	251	2	24863943
Pubmed	Hyperin protects against LPS-induced acute kidney injury by inhibiting TLR4 and NLRP3 signaling pathways.	NLRP3 TLR4	5.19e-05	2	251	2	27813491
Pubmed	Variation in the methylation profile and structure of Pax3 and Pax7 among different mouse strains and during expression.	PAX3 PAX7	5.19e-05	2	251	2	9016952
Pubmed	Aberrant Pax1 and Pax9 expression in Jarcho-Levin syndrome: report of two Caucasian siblings and literature review.	PAX1 PAX9	5.19e-05	2	251	2	12833407
Pubmed	Docking protein FRS2 links the protein tyrosine kinase RET and its oncogenic forms with the mitogen-activated protein kinase signaling cascade.	FRS2 RET	5.19e-05	2	251	2	11390647
Pubmed	Identification of two novel CAKUT-causing genes by massively parallel exon resequencing of candidate genes in patients with unilateral renal agenesis.	FREM2 FRAS1	5.19e-05	2	251	2	21900877
Pubmed	Genetic variants in FGFR2 and FGFR4 genes and skin cancer risk in the Nurses' Health Study.	FGFR2 FGFR4	5.19e-05	2	251	2	19500394
Pubmed	BioID screen of Salmonella type 3 secreted effectors reveals host factors involved in vacuole positioning and stability during infection.	HPS3 HPS5	5.19e-05	2	251	2	31611645
Pubmed	Notch Signaling Rescues Loss of Satellite Cells Lacking Pax7 and Promotes Brown Adipogenic Differentiation.	PAX3 PAX7	5.19e-05	2	251	2	27346341
Pubmed	Functional distinction of human EAG1 and EAG2 potassium channels.	KCNH1 KCNH5	5.19e-05	2	251	2	11943152
Pubmed	Anti-dsDNA antibodies bind to TLR4 and activate NLRP3 inflammasome in lupus monocytes/macrophages.	NLRP3 TLR4	5.19e-05	2	251	2	27250627
Pubmed	A transcription factor-based mechanism for mouse heterochromatin formation.	PAX3 PAX9	5.19e-05	2	251	2	22983563
Pubmed	USP9X promotes lipopolysaccharide-stimulated acute lung injury by deubiquitination of NLRP3.	USP9X NLRP3	5.19e-05	2	251	2	36525374
Pubmed	Molecular study of 33 families with Fraser syndrome new data and mutation review.	FREM2 FRAS1	5.19e-05	2	251	2	18671281
GeneFamily	Paired boxes	PAX1 PAX3 PAX7 PAX9	1.03e-06	9	175	4	675
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	PRTG OBSCN FGFR2 FGFR4 CNTN1 DSCAM HMCN1 ALPK2	1.75e-04	161	175	8	593
GeneFamily	Biogenesis of lysosomal organelles complex 2	HPS3 HPS5	2.78e-04	3	175	2	1038
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	PEG3 ZBTB8B ZNF766 ZNF844 ZNF114 ZNF729 ZNF789 ZNF607 ZFP30 ZNF101 ZHX2 ZNF181 ZNF45 ZNF69 ZFHX2 ZNF99 ZNF292	6.18e-04	718	175	17	28
GeneFamily	Bardet-Biedl syndrome associated\|BBSome	IFT172 BBS9 BBS12	1.04e-03	21	175	3	980
Coexpression	LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE	RALGAPA1 BCAS3 USP25 BTBD9 LRP1B KANK1 PIK3C2G FRAS1 USP24 FHOD3 UBR3 LRMDA	7.95e-07	208	249	12	M39233
Coexpression	CUI_TCF21_TARGETS_2_DN	IRF2BP2 LEMD3 NBEAL1 USP9X USP25 FRS2 DDN DIPK2A ADGRL4 PARP4 KANK1 AGO4 ZNF729 THSD7A DSP NATD1 ZNF101 PREX2 GUCY1A1 PDE4DIP TLR4 UBR3 LRMDA ZNF99 PLCE1	1.42e-06	888	249	25	MM1018
Coexpression	CUI_TCF21_TARGETS_2_DN	IRF2BP2 LEMD3 NBEAL1 USP9X USP25 FRS2 DDN DIPK2A ADGRL4 PARP4 KANK1 AGO4 ZNF729 THSD7A DSP NATD1 PREX2 GUCY1A1 PDE4DIP TLR4 UBR3 LRMDA PLCE1	7.89e-06	854	249	23	M1533
Coexpression	GSE37416_CTRL_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN	TTC21A GABARAPL2 NDUFA5 DIPK2A DIAPH1 ERO1A ZHX2 INTS13 HPS5 ZNF292	2.32e-05	200	249	10	M5338
Coexpression	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS	CFH REEP1 PSG5 USP9X CLK4 TRIM77 PIK3C2G OTULINL UBE2Z PRAMEF22 ERO1A PTPN23 FHOD3 ZNF101 OGDH RRN3 GZMA PDE4DIP PRKAR1A CTNND1 ENPEP MINDY1	3.31e-05	871	249	22	MM1005
Coexpression	GSE12707_AT16L1_HYPOMORPH_VS_WT_THYMUS_DN	ZBTB8B SRY GARIN1B TRIM42 ZHX2 RHOG CTNND1 ALPK2	3.55e-05	130	249	8	M434
Coexpression	GSE9946_MATURE_STIMULATORY_VS_LISTERIA_INF_MATURE_DC_DN	CPNE2 OBSCN DDN SRY FREM2 FGFR4 UNC45B ADAMTSL2	3.96e-05	132	249	8	M425
Coexpression	LAKE_ADULT_KIDNEY_C15_CONNECTING_TUBULE	RALGAPA1 BCAS3 USP25 BTBD9 LRP1B PIK3C2G FRAS1 FHOD3 LRMDA	3.99e-05	171	249	9	M39234
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FILIP1 REEP1 HPSE2 ITGA7 LRP1B PDLIM3 CNTN1 CAMK2B SYNE1 FHOD3 FAM153B UNC45B	1.51e-09	198	251	12	22e766df1276c5b14aa0d83f434f47140ebb98ea
ToppCell	COVID-19-Heart-CM_3\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FILIP1 SPTB OBSCN ITGA7 PDLIM3 DDX60L FHOD3 UNC45B PDE4DIP ADPRHL1 ALPK2	5.32e-09	176	251	11	9df7a124ebafb0087da0cda133a394275d7bed81
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ADGRB3 HPSE2 SVEP1 FGFR4 CNTN1 FRAS1 THSD7A PREX2 HMCN1 GUCY1A1 ENPEP	1.12e-08	189	251	11	203c80030df08ae112f9ae4043709f455d87ce89
ToppCell	Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|World / Lineage, Cell type, age group and donor	FILIP1 NBEAL1 BTBD9 MYO5C FREM2 KANK1 PTPRK FGFR2 DSCAM CPM GOLGA8A	1.25e-08	191	251	11	d3733c8c4bda70c4390e5601fdda6188a64be944
ToppCell	COVID-19-Heart-Mito_CM\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FILIP1 SPTB OBSCN ITGA7 NEB PDLIM3 DSP CAMK2B UNC45B PDE4DIP ADPRHL1	1.72e-08	197	251	11	44e49943d62bfe622b40ad0460093d31540544df
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FILIP1 SPTB OBSCN PDLIM3 CAMK2B FHOD3 UNC45B PDE4DIP ADPRHL1 ALPK2	8.56e-08	181	251	10	719eb532453ab7cd7893726885bc75d74a10b21e
ToppCell	LV-07._Pericyte\|World / Chamber and Cluster_Paper	NBEAL1 ADGRB3 RIPOR3 MOCS1 PEAR1 CDC42BPA CPM GUCY1A1 ENPEP PLCE1	9.48e-08	183	251	10	273db6a3b00a93ca852498471187b642b5368185
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RGS22 OBSCN NEB LRP1B FREM2 PIK3C2G CNTN1 FRAS1 HMCN1 PLCE1	9.98e-08	184	251	10	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RGS22 OBSCN NEB LRP1B FREM2 PIK3C2G CNTN1 FRAS1 HMCN1 PLCE1	9.98e-08	184	251	10	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RGS22 OBSCN NEB LRP1B FREM2 PIK3C2G CNTN1 FRAS1 HMCN1 PLCE1	9.98e-08	184	251	10	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	COVID-19-Heart-CM_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FILIP1 SPTB OBSCN PDLIM3 CAMK2B FHOD3 UNC45B PDE4DIP ADPRHL1 ALPK2	1.05e-07	185	251	10	549eeb521c3985bff396ea0f202db21822efa51f
ToppCell	wk_08-11-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_2\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	SPTB PEG3 ITGA7 ADRA1D MOCS1 ZHX2 HMCN1 RERGL UNC45B PLCE1	1.16e-07	187	251	10	406ff9327d3109fe1e251629c4c617b00a573dc2
ToppCell	LA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	FILIP1 OBSCN ITGA7 NEB PDLIM3 CAMK2B PDE4DIP ADPRHL1 ALPK2 PLCE1	1.22e-07	188	251	10	6d249fe92d51a19da19ec14bb2262d394255d577
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	BTBD9 MYO5C FREM2 KANK1 PTPRK FGFR2 FRAS1 CPM GOLGA8B GOLGA8A	1.35e-07	190	251	10	8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e
ToppCell	PND14-Mesenchymal-Mesenchymal_structural\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CFH PEG3 SVEP1 FGFR4 CXCL14 CPM PREX2 LOXL1 ENPEP ADAMTSL2	1.48e-07	192	251	10	25492568f9cbe097b7bb1db50d8b817c80ea87d7
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CFH PEG3 SVEP1 FGFR4 CXCL14 CPM PREX2 LOXL1 ENPEP ADAMTSL2	1.48e-07	192	251	10	de9c1536d5aee86f9c62acbc54ca8fa581c00f17
ToppCell	nucseq-Epithelial-Epithelial_Alveolar\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FILIP1 MYO9A BTBD9 MYO5C FREM2 KANK1 PTPRK FGFR2 SYNE1 CTNND1	1.63e-07	194	251	10	53f3e49e91b1096f3226010e2de767efb490dfe4
ToppCell	15-Airway-Mesenchymal-Pericyte\|Airway / Age, Tissue, Lineage and Cell class	FILIP1 BCAS3 SPTB ITGA7 ADRA1D MOCS1 HMCN1 GUCY1A1 RERGL UNC45B	1.63e-07	194	251	10	5c1218d239c88082496924653ed2a092dc44a906
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CFH PEG3 SVEP1 FGFR4 CXCL14 CPM PREX2 LOXL1 ENPEP ADAMTSL2	1.71e-07	195	251	10	3a0cad69cfc150a27a0666f612f5294c817197d7
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CFH PEG3 SVEP1 FGFR4 CXCL14 CPM PREX2 LOXL1 ENPEP ADAMTSL2	1.71e-07	195	251	10	2b8ee7990267bb52b7e6ae03f509ffebf8908122
ToppCell	metastatic_Brain-Fibroblasts-Pericytes\|Fibroblasts / Location, Cell class and cell subclass	FILIP1 ITGA7 PDLIM3 PTPRK CPM GUCY1A1 RERGL PRKAR1A ENPEP PLCE1	1.98e-07	198	251	10	86a4c8e859ce11a95875f8844963baeb1ba898ec
ToppCell	(5)_Fibroblast-G\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	CFH FILIP1 SVEP1 PDLIM3 FGFR4 FRAS1 GSTM5 HMCN1 ENPEP ADAMTSL2	2.07e-07	199	251	10	b4a737575be9f8c65771832dd8cd25328d5dae0d
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LRP1B CNTNAP5 KANK1 NOS1 CNTN1 GPR17 DSCAM SYNE1 USP24 IGSF21	2.07e-07	199	251	10	19a97e27a4758e794ce7246d295e112b47931a48
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LRP1B CNTNAP5 KANK1 NOS1 CNTN1 GPR17 DSCAM SYNE1 USP24 IGSF21	2.07e-07	199	251	10	e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LRP1B CNTNAP5 KANK1 NOS1 CNTN1 GPR17 DSCAM SYNE1 USP24 IGSF21	2.07e-07	199	251	10	333056c2abe9724efeab542c0365fcfe4eff8f18
ToppCell	medial-mesenchymal-Alveolar_Fibroblast\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CFH FILIP1 SVEP1 PDLIM3 FGFR4 FRAS1 GSTM5 HMCN1 LOXL1 ENPEP	2.17e-07	200	251	10	c22cbfecee00183dd4be678f116ab9fd9ad0a4dd
ToppCell	medial-2-mesenchymal-Alveolar_Fibroblast\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CFH FILIP1 SVEP1 PDLIM3 FGFR4 FRAS1 GSTM5 HMCN1 LOXL1 ENPEP	2.17e-07	200	251	10	cc6062dac07916c29091fc6bee2b864d29e6525b
ToppCell	medial-mesenchymal-Alveolar_Fibroblast-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CFH FILIP1 SVEP1 PDLIM3 FGFR4 FRAS1 GSTM5 HMCN1 LOXL1 ENPEP	2.17e-07	200	251	10	5c0716bf375c8158f7dc2c82bf5eaf37af594dd0
ToppCell	E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_1\|E16.5-samps / Age Group, Lineage, Cell class and subclass	CFH SVEP1 FGFR4 PREX2 GSTM2 LOXL1 PAX3 ENPEP ADAMTSL2	3.84e-07	163	251	9	f1ec2625b52664308968b01d8e0275e1e0751480
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FILIP1 MYO5C FREM2 PTPRK FGFR2 FRAS1 THSD7A DSCAM CPM	6.34e-07	173	251	9	b799c06a6a5754668e789f70c0c8bc1508568575
ToppCell	Basal_cells-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	CFH HSD17B13 ZFP30 FHOD3 HMCN1 LOXL1 CYB561D1 OGDHL PAX1	6.66e-07	174	251	9	a0060be3940043015dcc49a5157de5541aed24a1
ToppCell	Adult-Endothelial-endothelial_cell_of_artery-D175\|Adult / Lineage, Cell type, age group and donor	TOPAZ1 LRP1B ADGRL4 SYNJ2 NOS1 EXOC6 THSD7A PREX2 ARAP3	6.98e-07	175	251	9	0a65ddfa8c2e8efb5b5338cf07661cb78157a23c
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CPNE2 PRTG SVEP1 KANK1 THSD7A CXCL14 PREX2 GSTM2 PLCE1	8.05e-07	178	251	9	3c973aac16988e88f5677d3d695dd772ccfd6570
ToppCell	COVID-19-Heart-Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	NBEAL1 ADGRB3 RIPOR3 ITGA7 MOCS1 CPM GUCY1A1 ENPEP PLCE1	1.06e-06	184	251	9	21790cdfa3b4036ad413fd44b94e31563116f25f
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CFH SYNJ2 ARHGAP23 CAMK2B SYNE1 KCNT2 LOXL1 ALPK2 PLCE1	1.27e-06	188	251	9	b21e93a70583c30d05c0833cd3d4d4bca44a039e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CFH SYNJ2 ARHGAP23 CAMK2B SYNE1 KCNT2 LOXL1 ALPK2 PLCE1	1.27e-06	188	251	9	874404a4fd9aa42873f6c53dc42da22d3b0fdb9e
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 REEP1 HPSE2 ITGA7 PDLIM3 KCNT2 RERGL UNC45B PLCE1	1.33e-06	189	251	9	127ad2ba3e794df8cce2eee3e4171bccb5aad51b
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 REEP1 HPSE2 ITGA7 PDLIM3 KCNT2 RERGL UNC45B PLCE1	1.33e-06	189	251	9	2cfb4d12f75678d1619f4743838a0e954bd57761
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_artery\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ADGRL4 SYNJ2 NOS1 EXOC6 GPR17 CDC42BPA THSD7A PREX2 HMCN1	1.38e-06	190	251	9	f6c38d197fd9d69a4f97cb2e72cd4747984c1a86
ToppCell	droplet-Heart-nan-3m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFH PEG3 DSP GSTM5 KCNT2 GUCY1A1 LOXL1 PDE4DIP ADAMTSL2	1.38e-06	190	251	9	96a92212ea3fb35fa3d0da495e504edc61c71c23
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PRTG MCCC1 MYO5C FREM2 KANK1 PTPRK FGFR2 CPM GUCY1A1	1.45e-06	191	251	9	a0332a4ef629510fb313ec119195c44a3f704a80
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CFH SVEP1 DIPK2A FGFR4 CXCL14 PREX2 LOXL1 ENPEP ADAMTSL2	1.45e-06	191	251	9	6609d85fd2577633dcc067507304a6f9e5865ca3
ToppCell	human_hepatoblastoma-Hepatic_Stellate_cells\|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)	CFH FILIP1 ADGRB3 PDLIM3 PEAR1 KCNT2 GUCY1A1 ENPEP PLCE1	1.45e-06	191	251	9	78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CFH SVEP1 DIPK2A FGFR4 CXCL14 PREX2 LOXL1 ENPEP ADAMTSL2	1.45e-06	191	251	9	beb5bb42bd53bce01339da9110d374901548793c
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	BTBD9 MYO5C FREM2 KANK1 PTPRK FGFR2 CPM GOLGA8B GOLGA8A	1.45e-06	191	251	9	ca5669bd6f4a17471acae3eb229f845cc2e08efa
ToppCell	facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FILIP1 USP9X INSM1 PEG3 RET PDE4DIP PAXIP1 OGDHL PC	1.51e-06	192	251	9	5b7093d5af5ae7b0e6d3a464cc56272440ecedad
ToppCell	droplet-Heart-nan-24m-Mesenchymal-cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPTB INSM1 OBSCN FREM2 DSP FHOD3 PDE4DIP ADPRHL1 ALPK2	1.51e-06	192	251	9	f6a4e348406a852ace9fb21db8fbdff539217645
ToppCell	droplet-Heart-nan-24m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPTB INSM1 OBSCN FREM2 DSP FHOD3 PDE4DIP ADPRHL1 ALPK2	1.51e-06	192	251	9	1a0c25106ae08eac912a4edd5fc1a3ee776f69c2
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	BTBD9 FREM2 KANK1 PTPRK PIK3C2G FGFR2 RAP1GAP CPM LRMDA	1.51e-06	192	251	9	fb2f0e897228f808d9ff734ad05e9b49dc38fa50
ToppCell	wk_15-18-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_2\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	BCAS3 SPTB ITGA7 ADRA1D MOCS1 HMCN1 RERGL UNC45B PLCE1	1.58e-06	193	251	9	360079cbaa18b74e4a48c5de40844faca076e1a6
ToppCell	Fetal_29-31_weeks-Epithelial\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	BTBD9 MYO5C FREM2 KANK1 PTPRK FGFR2 CPM GOLGA8B GOLGA8A	1.58e-06	193	251	9	a0ca3231992f14abcf1a6129573bace320e89d2a
ToppCell	nucseq-Epithelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FILIP1 MYO9A BTBD9 MYO5C KANK1 PTPRK FGFR2 SYNE1 CTNND1	1.72e-06	195	251	9	9406866f99555198a9be311fbd65751b70f35446
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PEG3 SVEP1 FGFR4 CXCL14 PREX2 GSTM2 LOXL1 ENPEP ADAMTSL2	1.79e-06	196	251	9	97e26622d9582b092c18ff5b7e957818f99d9631
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PEG3 SVEP1 FGFR4 CXCL14 PREX2 GSTM2 LOXL1 ENPEP ADAMTSL2	1.79e-06	196	251	9	f429f045ba45e24717963315832150b12a115bfa
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 SVEP1 PDLIM3 LDLRAD4 SYNE1 RFX2 PREX2 LOXL1 ADAMTSL2	1.87e-06	197	251	9	85a8f1d18e0dd1d31341f5131eecd217553bf042
ToppCell	10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-A\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CFH FILIP1 PRSS3 ADGRL4 PEAR1 DSP CUBN PREX2 HMCN1	1.87e-06	197	251	9	9e948b2e0f7e426f1e6f95bbbf4282fbddc2b99d
ToppCell	Control_saline-Epithelial_alveolar-AT_2\|Control_saline / Treatment groups by lineage, cell group, cell type	FILIP1 MYO5C FGFR2 RAP1GAP DSP CPM CCDC39 NIM1K OGDHL	1.87e-06	197	251	9	b8f62fcd6eb8f47b3cc41f616126f82c68a36e87
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ITGA7 ADRA1D PDLIM3 MOCS1 PEAR1 PREX2 GUCY1A1 RERGL PLCE1	1.87e-06	197	251	9	01249bd485a3734de87ae6ed9c749597f39c6335
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 SVEP1 PDLIM3 LDLRAD4 SYNE1 RFX2 PREX2 LOXL1 ADAMTSL2	1.87e-06	197	251	9	e8e3ba791dfaa0fab35e0329a5e34376f9ee6143
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CFH FILIP1 RIPOR3 HPSE2 SVEP1 PDLIM3 CNTN1 KCNT2 ADAMTSL2	1.87e-06	197	251	9	80e153790cef37b743e22a7370ff5b3a6abf147d
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	FILIP1 ADGRB3 LRP1B SVEP1 FGFR4 CNTN1 FRAS1 THSD7A LOXL1	1.87e-06	197	251	9	0034bae02ee7fcfea520d453ca3c842ab6963b12
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	FILIP1 ADGRB3 LRP1B SVEP1 FGFR4 CNTN1 THSD7A GUCY1A1 LOXL1	1.87e-06	197	251	9	11a4c417f035e554431a8f03be13b5eefa3530c0
ToppCell	distal-2-mesenchymal-Vascular_Smooth_Muscle\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	FILIP1 SPTB ITGA7 ADRA1D PDLIM3 MOCS1 KCNT2 GUCY1A1 ENPEP	1.95e-06	198	251	9	ce05ede69c167b2294630709bb0c223483a6ef75
ToppCell	Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1\|Control_saline / Treatment groups by lineage, cell group, cell type	FILIP1 NBEAL1 MYO5C FRAS1 DSP CPM OGDHL HPS5 PLCE1	1.95e-06	198	251	9	85f424cd9bb3117c9e322031024aabb87696ce47
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PRTG MCCC1 MYO5C FREM2 KANK1 PTPRK FGFR2 CPM NIM1K	1.95e-06	198	251	9	f948391296c261c473d339069a6d0f20ccd6f38f
ToppCell	background-Hepatic_Stellate_cells\|background / Sample and Cell Type and Tumor Cluster (all cells)	ADGRB3 RIPOR3 SVEP1 PDLIM3 CXCL14 FHOD3 COLEC10 HMCN1 ADAMTSL2	1.95e-06	198	251	9	bd11b0e9e80449aab979a02c1023e0638c431c7c
ToppCell	Parenchymal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYO9A MCCC1 BTBD9 MYO5C FREM2 KANK1 PTPRK FGFR2 CPM	2.03e-06	199	251	9	5cea0d9e261903e0eaad60c28a07dff72ce65027
ToppCell	Control_saline\|World / Treatment groups by lineage, cell group, cell type	MAP4K2 EXOC6 FRAS1 DSP COLEC10 ARAP3 HMCN1 CTNND1 ADAMTSL2	2.03e-06	199	251	9	11c9c1779caceb725ecccf3f23b7d4e6dbd1af64
ToppCell	5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PRTG MYO9A MCCC1 F11 FREM2 KANK1 SYNE1 CPM GUCY1A1	2.03e-06	199	251	9	2dc33804f6691d7c9682e6c9b885e945fb97fc36
ToppCell	distal-2-mesenchymal-Airway_Smooth_Muscle\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	FILIP1 SPTB ITGA7 PDLIM3 MOCS1 GUCY1A1 RERGL UNC45B LOXL1	2.03e-06	199	251	9	af226a6c50747dad9ca696463e715913b3ac17c0
ToppCell	distal-mesenchymal-Alveolar_Fibroblast\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CFH FILIP1 SVEP1 PDLIM3 FGFR4 GSTM5 HMCN1 LOXL1 ENPEP	2.03e-06	199	251	9	655d07cf9a2fd9b945a2ed4f824cba0297de72a8
ToppCell	distal-mesenchymal-Airway_Smooth_Muscle-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	FILIP1 IP6K3 SPTB ITGA7 PDLIM3 MOCS1 GUCY1A1 RERGL UNC45B	2.11e-06	200	251	9	f09eaa52e11262ec47f3dcb4d890e240eaaa2b3d
ToppCell	distal-3-mesenchymal-Alveolar_Fibroblast\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CFH FILIP1 SVEP1 PDLIM3 FGFR4 GSTM5 HMCN1 LOXL1 ENPEP	2.11e-06	200	251	9	20112be28f80baffad92641c9cfd7c3718967dbb
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 ITGA7 ADRA1D KCNH1 PEAR1 KCNT2 RERGL PLCE1	2.46e-06	152	251	8	0cb5f4dfae04e3f4eba502bbf229007d5fa3884d
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 ITGA7 ADRA1D KCNH1 PEAR1 KCNT2 RERGL PLCE1	2.46e-06	152	251	8	ba89ffb5a8bb33c188f854f54b39123b6d73496a
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Lypd1_Gpr88\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ADRA1D PTPRK KCNH1 HSD17B13 FRAS1 THSD7A FHOD3 KCNH5	3.13e-06	157	251	8	5aee90ad7aaa65fdabc23597451da5e48db8f4e6
ToppCell	Children_(3_yrs)-Epithelial-basal_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CFH LRP1B FGFR2 CNTN1 FRAS1 FHOD3 PAX9 GOLGA8A	3.29e-06	158	251	8	d78e7e52657dc094430291fec07e9c298be9e584
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PRTG KCNH7 LRP1B PIK3C2G FRAS1 FHOD3 HMCN1 LRMDA	3.29e-06	158	251	8	7960337d87afecf2692ab65e5991f052ceddfacc
ToppCell	Basal_cells-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	EPPK1 HSD17B13 ARHGAP23 MAN1C1 CAMK2B CXCL14 ORC5 PAX9	4.14e-06	163	251	8	679e25e5548d157d49a73057a3b5617dccda260f
ToppCell	TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5\|TCGA-Ovary / Sample_Type by Project: Shred V9	DCAF1 IFT172 TTC21A OBSCN SZT2 USP24 PTPN23 UTP25	4.74e-06	166	251	8	32d2eaf8a5d03881bf74d680825af2d5110b082d
ToppCell	Adult-Mesenchymal-myofibroblast_cell\|Adult / Lineage, Cell type, age group and donor	CFH HPSE2 PDLIM3 SYNJ2 KCNT2 HMCN1 NANOS3 ADAMTSL2	4.95e-06	167	251	8	d584a8548a5317bd9686b3be8246ae6ed568796b
ToppCell	Adult-Endothelial-endothelial_cell_of_artery-D231\|Adult / Lineage, Cell type, age group and donor	SPTB ADGRL4 NOS1 EXOC6 THSD7A PREX2 ARAP3 NANOS3	5.17e-06	168	251	8	aca34c51758c65925ad24110294a72b2dea6db72
ToppCell	390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_5\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	HLA-DQB2 ADGRL4 PDLIM3 ZNF844 CDC42BPA HMCN1 GUCY1A1 PAXIP1	5.17e-06	168	251	8	d7d19c93d1c3dd994e18e28d5f36ae7773ff5d7f
ToppCell	tumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs\|Fibroblasts / Location, Cell class and cell subclass	CFH MCCC1 SVEP1 FGFR4 OTULINL CXCL14 GOLGA8B ZNF292	5.41e-06	169	251	8	84b898a9fd8ced67c6a501d5cef6416f519902c4
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CFH RIPOR3 SVEP1 CNTN1 PEAR1 POLA1 ATAD2 ADAMTSL2	5.41e-06	169	251	8	a84490724a206c9bbb145f7ce08613f91d100ac4
ToppCell	facs-Large_Intestine-Proximal-24m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPPK1 RGS22 ADGRB3 ADRA1D CAMK2B RHOG OGDHL LRMDA	5.65e-06	170	251	8	c638dfde9ce30190abbe0caea1c3eb874af09857
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CHST6 ADGRL4 NOS1 EXOC6 THSD7A PREX2 ARAP3 HMCN1	5.89e-06	171	251	8	1597459c971d6befa991d59dc66b41b6a522f797
ToppCell	facs-Marrow-B-cells-24m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRB3 LRP1B NOS1 FRAS1 KCNT2 HMCN1 FCRL5 IGSF21	6.98e-06	175	251	8	887e75fc90e59a6394d62f3c048a9cfdf6707725
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CNTNAP5 PIK3C2G PLAAT4 DSCAM MAN1C1 PCNX4 LRMDA EXOSC7	7.59e-06	177	251	8	8e4005fad50e6f919da175f3b9ae58849dbd60b1
ToppCell	Children_(3_yrs)-Epithelial-basal_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CFH FGFR2 CNTN1 FRAS1 FHOD3 GOLGA8B PAX9 GOLGA8A	7.91e-06	178	251	8	fba2e38c05cbf031e0c6d47b1602575fea734a57
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CFH FILIP1 RIPOR3 SVEP1 CNTN1 GSTM5 KCNT2 ADAMTSL2	7.91e-06	178	251	8	78a0c6340001a77f5b2d890b6263f574af2e72da
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MYO5C FREM2 PTPRK FGFR2 FRAS1 THSD7A DSCAM CPM	8.24e-06	179	251	8	cb38b54261a7af5ee3347e64c8aa880a77ed0763
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CPNE2 PRTG SVEP1 KANK1 ZNF114 THSD7A CXCL14 PLCE1	8.24e-06	179	251	8	01302505816f272243659e20d751b61a198a2fc0
ToppCell	droplet-Kidney-nan-18m-Epithelial-Stroma____kidney_mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FILIP1 ITGA7 PDLIM3 CNTN1 GUCY1A1 RERGL LOXL1 PLCE1	8.58e-06	180	251	8	b6f44fdedc33b7d93b0074e8e9c8cc32009d4c4d
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	KCNH7 KANK1 PIK3C2G NOS1 USP24 FHOD3 HMCN1 LRMDA	8.94e-06	181	251	8	e0abf2707d9e0aa942c657eef7d2cbcd02f060dd
ToppCell	RA-07._Pericyte\|RA / Chamber and Cluster_Paper	NBEAL1 ADGRB3 RIPOR3 MOCS1 THSD7A CPM GUCY1A1 ENPEP	8.94e-06	181	251	8	8dfb42d096db6c2df9b41303a7199d134d4bff07
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CPNE2 PRTG SVEP1 THSD7A CXCL14 PREX2 KCNT2 PLCE1	8.94e-06	181	251	8	062f00736eed96e4f4327615d093558dd7d82b20
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FREM2 KANK1 PIK3C2G FRAS1 THSD7A MAN1C1 FHOD3 RERGL	8.94e-06	181	251	8	aa233b652921848af2257cc3687a7a09c3acfb67
ToppCell	COVID-19-kidney-Epithelial_Doublet\|COVID-19 / Disease (COVID-19 only), tissue and cell type	KCNH7 TOPAZ1 HPSE2 TRIM77 LRP1B CNTNAP5 KCNH5	9.12e-06	130	251	7	1ff28e9d3dc9a791e07d815f8fbb48f75d3f275b
ToppCell	E18.5-samps-Mesenchymal-Matrix_fibroblast\|E18.5-samps / Age Group, Lineage, Cell class and subclass	CFH PEG3 SVEP1 FGFR4 PREX2 GSTM2 PAX3 ENPEP	9.30e-06	182	251	8	ceb37c214662a48efb56ab0d015977c6fab478b0
Drug	Etoposide [33419-42-0]; Down 200; 6.8uM; PC3; HT_HG-U133A	DCAF1 REEP1 IQSEC2 FRS2 DDN BBS9 NOS1 CDC42BPA SYNE1 ZFP30 FHOD3 PREX2 ZNF292	3.16e-07	198	250	13	6681_DN
Disease	complement factor H-like 1 protein measurement	CFH FREM2 SYNJ2 THSD7A KCNT2	8.89e-07	22	245	5	EFO_0600092
Disease	Polydactyly	USP9X IFT172 BBS9 FREM2 PIK3R2 FGFR2 FRAS1 BBS12	6.31e-06	117	245	8	C0152427
Disease	epilepsy (implicated_via_orthology)	KCNH7 ITGA7 LRP1B KCNH1 SCN4A NOS1 RHOG KCNT2 KCNH5	9.55e-06	163	245	9	DOID:1826 (implicated_via_orthology)
Disease	Unilateral agenesis of kidney	FREM2 FRAS1 RET	3.07e-05	8	245	3	C0266294
Disease	complement factor B measurement	CFH NELFE KCNT2	4.58e-05	9	245	3	EFO_0008096
Disease	Prescription Drug Abuse	MYO5C DSCAM SYNE1 CXCL14 FHOD3 WDR11 LRMDA	5.11e-05	115	245	7	C4316881
Disease	Substance-Related Disorders	MYO5C DSCAM SYNE1 CXCL14 FHOD3 WDR11 LRMDA	5.11e-05	115	245	7	C0236969
Disease	Organic Mental Disorders, Substance-Induced	MYO5C DSCAM SYNE1 CXCL14 FHOD3 WDR11 LRMDA	5.11e-05	115	245	7	C0029231
Disease	Drug habituation	MYO5C DSCAM SYNE1 CXCL14 FHOD3 WDR11 LRMDA	5.11e-05	115	245	7	C0013170
Disease	Drug abuse	MYO5C DSCAM SYNE1 CXCL14 FHOD3 WDR11 LRMDA	5.11e-05	115	245	7	C0013146
Disease	Drug Use Disorders	MYO5C DSCAM SYNE1 CXCL14 FHOD3 WDR11 LRMDA	5.11e-05	115	245	7	C0013222
Disease	Drug Dependence	MYO5C DSCAM SYNE1 CXCL14 FHOD3 WDR11 LRMDA	5.11e-05	115	245	7	C1510472
Disease	Substance Dependence	MYO5C DSCAM SYNE1 CXCL14 FHOD3 WDR11 LRMDA	5.11e-05	115	245	7	C0038580
Disease	Substance Use Disorders	MYO5C DSCAM SYNE1 CXCL14 FHOD3 WDR11 LRMDA	5.11e-05	115	245	7	C0038586
Disease	Substance abuse problem	MYO5C DSCAM SYNE1 CXCL14 FHOD3 WDR11 LRMDA	5.40e-05	116	245	7	C0740858
Disease	fibroblast growth factor 8 isoform b measurement	CFH NELFE	6.87e-05	2	245	2	EFO_0020386
Disease	3,7-dimethylurate measurement	GSTM2 GSTM5	6.87e-05	2	245	2	EFO_0800949
Disease	BMP-binding endothelial regulator protein measurement	CFH BBS9	6.87e-05	2	245	2	EFO_0020183
Disease	lactoylglutathione lyase measurement	CFH BTBD9	6.87e-05	2	245	2	EFO_0802684
Disease	oxoglutarate dehydrogenase deficiency (implicated_via_orthology)	OGDH OGDHL	6.87e-05	2	245	2	DOID:0081326 (implicated_via_orthology)
Disease	Colorectal Carcinoma	PEG3 ZBTB8B OBSCN PSMC5 LPIN1 CNTN1 SYNE1 RET CUBN PREX2 HPS3 CNPPD1 ARAP3 INTS13 TLR4 IGSF21 ZNF292	8.93e-05	702	245	17	C0009402
Disease	RHABDOMYOSARCOMA 2	PAX3 PAX7	2.05e-04	3	245	2	268220
Disease	dementia, Parkinson disease, disease progression measurement	BBS9 LRP1B	2.05e-04	3	245	2	EFO_0008336, MONDO_0001627, MONDO_0005180
Disease	Alveolar rhabdomyosarcoma	PAX3 PAX7	2.05e-04	3	245	2	cv:C0206655
Disease	complement C3 measurement	CFH KCNT2	2.05e-04	3	245	2	EFO_0004983
Disease	Cryptophthalmos syndrome	FREM2 FRAS1	2.05e-04	3	245	2	C0265233
Disease	alveolar rhabdomyosarcoma (is_implicated_in)	PAX3 PAX7	2.05e-04	3	245	2	DOID:4051 (is_implicated_in)
Disease	FRASER SYNDROME 1	FREM2 FRAS1	2.05e-04	3	245	2	C4551480
Disease	ras-related protein Rab-27B measurement	CFH NELFE	2.05e-04	3	245	2	EFO_0802993
Disease	Malignant neoplasm of breast	OBSCN FEM1C SYNJ2 KCNH1 MROH7 FGFR2 HERC2 RANBP1 RAP1GAP SYNE1 MAGEE1 CUBN RFX2 MOSPD1 ARAP3 LLGL1 KCNT2 UNC45B EHMT1 FCRL5 ENPEP	2.70e-04	1074	245	21	C0006142
Disease	autism spectrum disorder (implicated_via_orthology)	CNTNAP5 CHD6 DSCAM CHD8 GSTM5 MAPK1 CTNND1	2.91e-04	152	245	7	DOID:0060041 (implicated_via_orthology)
Disease	coronary artery disease, factor VII measurement	NBEAL1 ADH5 NFS1 MPIG6B GUCY1A1 NANOS3	3.37e-04	111	245	6	EFO_0001645, EFO_0004619
Disease	Congenital small ears	LEMD3 FREM2 FGFR2 FRAS1	3.69e-04	41	245	4	C0152423
Disease	severe acute respiratory syndrome, COVID-19	USP9X BBS9 LRP1B SYNJ2 PIK3C2G THSD7A LGALS12 PREX2 RERGL PDE4DIP GOLGA8B GOLGA8A	3.94e-04	447	245	12	EFO_0000694, MONDO_0100096
Disease	Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 measurement	SVEP1 PEAR1	4.07e-04	4	245	2	EFO_0803113
Disease	Fraser syndrome (implicated_via_orthology)	FREM2 FRAS1	4.07e-04	4	245	2	DOID:0090001 (implicated_via_orthology)
Disease	Endometrial adenocarcinoma	PIK3R2 FGFR2	4.07e-04	4	245	2	C1153706
Disease	factor XI measurement, coronary artery disease	NBEAL1 BCAS3 F11 MPIG6B GUCY1A1 NANOS3	4.08e-04	115	245	6	EFO_0001645, EFO_0004694
Disease	serum IgG glycosylation measurement	TOPAZ1 HLA-DQB2 LRP1B ADGRL4 ADRA1D CNTNAP5 CNTN1 THSD7A DSCAM CPM TLR4 GOLGA8B ENPEP	4.71e-04	523	245	13	EFO_0005193
Disease	sucrose liking measurement	ORC5 GOLGA8B GOLGA8A	5.81e-04	20	245	3	EFO_0010157
Disease	urethral obstruction (biomarker_via_orthology)	NOS1 MAPK1	6.75e-04	5	245	2	DOID:12577 (biomarker_via_orthology)
Disease	Alveolar rhabdomyosarcoma	PAX3 PAX7	6.75e-04	5	245	2	C0206655
Disease	Malignant neoplasm of thyroid	RET PRKAR1A	6.75e-04	5	245	2	C0007115
Disease	fructose-1,6-bisphosphatase isozyme 2 measurement	CFH PCNX4	6.75e-04	5	245	2	EFO_0802556
Disease	bone disease (implicated_via_orthology)	FGFR2 FGFR4	6.75e-04	5	245	2	DOID:0080001 (implicated_via_orthology)
Disease	Brugada syndrome (implicated_via_orthology)	GSTM2 GSTM5	6.75e-04	5	245	2	DOID:0050451 (implicated_via_orthology)
Disease	sleep efficiency	GOLGA8B GOLGA8A	6.75e-04	5	245	2	EFO_0803364
Disease	glutathione S-transferase Mu 1 measurement	GSTM2 GSTM5	6.75e-04	5	245	2	EFO_0801638
Disease	forced expiratory volume	FILIP1 BCAS3 HLA-DQB2 FRS2 BBS9 SVEP1 SCN4A FGFR2 THSD7A DSCAM SYNE1 ZHX2 WDR11 LOXL1 LRMDA PC	9.92e-04	789	245	16	EFO_0004314
Disease	tumor necrosis factor ligand superfamily member 18 measurement	CFH NELFE	1.01e-03	6	245	2	EFO_0020795
Disease	clubfoot (implicated_via_orthology)	FRAS1 RET	1.01e-03	6	245	2	DOID:11836 (implicated_via_orthology)
Disease	killer cell immunoglobulin-like receptor 2DL2 measurement	CFH NELFE	1.01e-03	6	245	2	EFO_0801744
Disease	cataract	HLA-DQB2 LRP1B HERC2 CDC42BPA THSD7A PLCE1	1.19e-03	141	245	6	MONDO_0005129
Disease	Hypertrophic Cardiomyopathy	OBSCN PDLIM3 DSP FHOD3	1.30e-03	57	245	4	C0007194
Disease	reaction time measurement	KCNH7 REEP1 TOPAZ1 DDN ADRA1D PTPRK EIF3K CHD6 LDLRAD4 CNTN1 ARHGAP23 UTP25 TMEM168 PC	1.30e-03	658	245	14	EFO_0008393
Disease	S-warfarin measurement	LRP1B LDLRAD4 EXOC6 ZHX2 ADPRHL1	1.31e-03	97	245	5	EFO_0803323
Disease	CHARGE syndrome (implicated_via_orthology)	CHD6 CHD8	1.40e-03	7	245	2	DOID:0050834 (implicated_via_orthology)
Disease	Hermansky-Pudlak syndrome (is_implicated_in)	HPS3 HPS5	1.40e-03	7	245	2	DOID:3753 (is_implicated_in)
Disease	exfoliation syndrome (is_implicated_in)	LOXL1 TLR4	1.40e-03	7	245	2	DOID:13641 (is_implicated_in)
Disease	toll-like receptor 4:Lymphocyte antigen 96 complex measurement	CFH TLR4	1.40e-03	7	245	2	EFO_0008301
Disease	leucine-rich repeat-containing protein 15 measurement	CPNE2 COLEC10	1.40e-03	7	245	2	EFO_0801761
Disease	aspartate aminotransferase measurement	CFH HLA-DQB2 OBSCN HPSE2 ADH5 LPIN1 HSD17B13 FGFR4 THSD7A ZNF101 CUBN NLRP3 GSTM2 WDR11 IGSF21 ALPK2 PLCE1	1.56e-03	904	245	17	EFO_0004736
Disease	complement factor H-related protein 2 measurement	CFH KCNT2 LRMDA	1.76e-03	29	245	3	EFO_0600055
Disease	Abnormality of the skeletal system	WDR37 ZNF292	1.86e-03	8	245	2	C4021790
Disease	anterior uveitis (is_implicated_in)	CFH TLR4	1.86e-03	8	245	2	DOID:1407 (is_implicated_in)
Disease	Congenital Hand Deformities	PAX3 ADAMTSL2	1.86e-03	8	245	2	C0018566
Disease	Leigh syndrome	SCN4A PC	1.86e-03	8	245	2	cv:C0023264
Disease	PAX-interacting protein 1 measurement	CFH HLA-DQB2	1.86e-03	8	245	2	EFO_0801868
Disease	diastolic blood pressure, self reported educational attainment	PIK3C2G RERGL	1.86e-03	8	245	2	EFO_0004784, EFO_0006336
Disease	gdnf family receptor alpha-1 measurement	CFH HLA-DQB2	1.86e-03	8	245	2	EFO_0020400
Disease	glaucoma	BCAS3 LRP1B HERC2 THSD7A LOXL1 PLCE1	1.86e-03	154	245	6	MONDO_0005041
Disease	response to angiotensin receptor blocker	BCAS3 POLR1A ZHX2	1.95e-03	30	245	3	EFO_0010735
Disease	Age related macular degeneration	CFH HMCN1 TLR4	1.95e-03	30	245	3	C0242383
Disease	urate measurement, bone density	ADGRB3 RIPOR3 DHX33 CNTNAP5 DIAPH1 LDLRAD4 FRAS1 DSCAM MAN1C1 SYNE1 OGDH LRMDA KCNH5	2.15e-03	619	245	13	EFO_0003923, EFO_0004531
Disease	alkaline phosphatase measurement	RALGAPA1 IRF2BP2 ADH5 SYNJ2 UBE2E3 MAP4K2 LDLRAD4 RAP1GAP CAMK2B ZNF101 COLEC10 NLRP3 LLGL1 ZNF45 PRKAR1A ALPK2 ADAMTSL2 PLCE1	2.18e-03	1015	245	18	EFO_0004533
Disease	zinc fingers and homeoboxes protein 3 measurement	CFH HLA-DQB2	2.38e-03	9	245	2	EFO_0803299
Disease	collectin-10 measurement	CFH COLEC10	2.38e-03	9	245	2	EFO_0801491
Disease	beta-mannosidase measurement	CFH GOLGA8B	2.38e-03	9	245	2	EFO_0801421
Disease	HLA class II histocompatibility antigen, DQ alpha 2 chain measurement	CFH HLA-DQB2	2.38e-03	9	245	2	EFO_0801686
Disease	prostate cancer (implicated_via_orthology)	FGFR2 PAX3 PAX7	2.57e-03	33	245	3	DOID:10283 (implicated_via_orthology)
Disease	anorexia nervosa	ADGRL4 THSD7A WDR11 LRMDA	2.77e-03	70	245	4	MONDO_0005351
Disease	beta-defensin 1 measurement	LVRN CPNE2	2.96e-03	10	245	2	EFO_0801415
Disease	Congenital myasthenic syndrome	MYO9A SCN4A	2.96e-03	10	245	2	cv:C0751882
Disease	transmembrane glycoprotein NMB measurement	CFH PAX3	2.96e-03	10	245	2	EFO_0008303
Disease	Hermanski-Pudlak Syndrome	HPS3 HPS5	2.96e-03	10	245	2	C0079504
Disease	Facies	CHD8 ADAMTSL2	2.96e-03	10	245	2	C0282631
Disease	Abnormality of nervous system morphology	WDR37 ZNF292	2.96e-03	10	245	2	C4022810
Disease	Hermansky-Pudlak syndrome	HPS3 HPS5	2.96e-03	10	245	2	cv:C0079504
Disease	colorectal adenocarcinoma (is_implicated_in)	KCNH1 FGFR2 MAPK1	3.04e-03	35	245	3	DOID:0050861 (is_implicated_in)
Disease	Thyroid Neoplasm	RAP1GAP RET PRKAR1A	3.57e-03	37	245	3	C0040136
Disease	DNA repair protein RAD51 homolog 4 measurement	CFH ZNF789	3.59e-03	11	245	2	EFO_0801531
Disease	tumor necrosis factor receptor superfamily member 11B measurement	CFH COLEC10	3.59e-03	11	245	2	EFO_0020801
Disease	anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine	GLYATL1 FHOD3	3.59e-03	11	245	2	EFO_0803358, EFO_0803362
Disease	hemopexin measurement	CFH KCNT2	3.59e-03	11	245	2	EFO_0008149
Disease	response to virus	BBS9 FREM2	3.59e-03	11	245	2	GO_0009615
Disease	neuroimaging measurement	PRTG NBEAL1 HLA-DQB2 BBS9 FGFR2 ZSWIM4 UBE2Z EXOC6 CDC42BPA SZT2 ZHX2 ORC5 SEC14L6 TLR4 PAX3 PAX7 PC PLCE1	3.76e-03	1069	245	18	EFO_0004346
Disease	bilirubin measurement	BCAS3 HLA-DQB2 SPTB PSMC5 ADH5 EXOC6 ZNF101 NLRP3 GSTM2 WDR11	4.08e-03	442	245	10	EFO_0004570
Disease	Emery-Dreifuss muscular dystrophy (implicated_via_orthology)	LEMD3 SYNE1	4.29e-03	12	245	2	DOID:11726 (implicated_via_orthology)
Disease	Spina Bifida	FGFR2 PAX3	4.29e-03	12	245	2	C0080178
Disease	Status Dysraphicus	FGFR2 PAX3	4.29e-03	12	245	2	C0038219

Protein segments in the cluster

Peptide	Gene	Start	Entry
NCRVALRNDSYTLHK	PSMC5	111	P62195
TLSHRKVTDRYRSLC	ADGRL4	356	Q9HBW9
KELEAQCRRHGYAAL	ACTL10	181	Q5JWF8
VSRVARLKLYHLTCG	CYB561D1	156	Q8N8Q1
ARCHRIGQSKAVKVY	CHD8	1241	Q9HCK8
YGRTDCFRVEKHLLV	CHD8	1441	Q9HCK8
GIIILRSCKINRDYS	CPNE2	281	Q96FN4
LATLIGHLYRVQKCA	ARAP3	1031	Q8WWN8
RKARYHTLTKICAVQ	BAG5	146	Q9UL15
RCISNEYRHLQHSIK	ADGRB3	566	O60242
ACVLKVHNAIAYGTR	ALPK2	1951	Q86TB3
RIKIIATAVCHTDAY	ADH5	36	P11766
ITIIDRKVCNDRNHY	GZMA	171	P12544
TVVCLQLYREKASHH	GPR17	206	Q13304
QYLESRKCIHRDLAA	FGFR4	601	P22455
TYIVVQKRHHTRLFC	AGO1	701	Q9UL18
VETHQVHEYLRSKLC	PPP2R2D	326	Q66LE6
EKNYRESLTHCRIRG	COLEC10	166	Q9Y6Z7
HRACALRDTAYAIIK	ATAD2	1076	Q6PL18
RIKHRTGDEITYQCR	CFH	281	P08603
YIVVQKRHHTRLFCA	AGO4	706	Q9HCK5
VICDYDHVNRTERGK	LVRN	311	Q6Q4G3
AGSYDSRNKHEIIRC	DIAPH1	206	O60610
SCQGDYIRVRKAITA	DHX16	931	O60231
RKLGVTAHAYVVDCS	HSD17B13	81	Q7Z5P4
IEVKTISCHYSRRAP	DDN	36	O94850
AYAENKLIRCHQSRG	BCAS3	241	Q9H6U6
VTATHKTYRCNDLVE	BBS12	256	Q6ZW61
ADRKLLKCRTAYQDH	CCDC39	286	Q9UFE4
LKCRTAYQDHETSRI	CCDC39	291	Q9UFE4
AREVVRSSCINLYGK	MROH7	1096	Q68CQ1
TLRRCYSRVKEHGVG	MSANTD2	171	Q6P1R3
YQSHVLKDEAGRVLC	NANOS3	71	P60323
KCTNVYERSKQHIRL	NBEAL1	1166	Q6ZS30
RRDKTLKICANHYIT	RANBP1	91	P43487
EQDEHKCVVRYRGKT	C9orf64	81	Q5T6V5
SFTKIYRGCRHEVVD	JAK3	531	P52333
VELCCRAYNIIRKHS	PIK3C2G	1096	O75747
IAIARCYSLKNRHQD	PTPN23	1211	Q9H3S7
ETLCKITEYQHEART	INTS13	131	Q9NVM9
LRVSHGCVSKILCRY	PAX7	76	P23759
RPQVHYSCIRKEDIS	LLGL1	896	Q15334
VHIAVDKNSREGCVY	LEMD3	821	Q9Y2U8
RQIAYVCREALKGLH	MAP4K2	111	Q12851
YAQAIRERKRCVTAH	PAXIP1	661	Q6ZW49
LHLAVDKNTTCVGRY	FEM1C	486	Q96JP0
YLASQKCIHRDLAAR	FGFR2	616	P21802
HQTYCQRTLREIKIL	MAPK1	61	P28482
VGYDVSHIRCKSQLD	OTOP3	181	Q7RTS5
SIITEYLREQHARCK	DCAF1	1006	Q9Y4B6
LRVSHGCVSKILARY	PAX9	46	P55771
DRVEKNVNRHYCTVR	FRAS1	3956	Q86XX4
RELTSHQGVLGKCRY	LRMDA	166	Q9H2I8
KIERCEYDGSQRHVI	LRP1B	2386	Q9NZR2
VQAGRKHVITCRYLS	MAGEE1	866	Q9HCI5
AEIGRICSSRKVYFH	NFS1	216	Q9Y697
YTVEKCIQHVKRLRE	NFS1	421	Q9Y697
GCHRDKRTQIVYSDD	NELFE	356	P18615
ILRYIARKHNLCGET	GSTM5	76	P46439
LEHLQTSYCGLVRVD	LRR1	156	Q96L50
RYIEIAIKQCRSSGI	HERC2	2886	O95714
VTSEDLKRSYVCHAR	IL1RAP	321	Q9NPH3
RALTYCDLHKIQRED	KCNH7	826	Q9NS40
ATGLCKQTYQRETRH	IQSEC2	726	Q5JU85
CKAFQELGVRYRHTA	FREM2	256	Q5SZK8
YVSSEHKGRRVTALC	HPS5	116	Q9UPZ3
RALTYCDLHIIKREA	KCNH5	631	Q8NCM2
QRAHLYSLRCAAEEK	LOXL1	386	Q08397
CTYADVKALHTEITR	DDX60L	1201	Q5H9U9
YNILKTCRGHTLERS	CARM1	121	Q86X55
RAEHALQRSYCINKL	EXTL2	286	Q9UBQ6
VDKVCRHNYEAELRT	HLA-DQB2	106	P05538
VLRQLECYHSEEKAS	PCNX4	941	Q63HM2
LHCETQEDSLRTLYR	FCRL5	306	Q96RD9
RELRISGSVQLYCVH	LGALS12	321	Q96DT0
KDVVVDLVCYRRRGH	OGDHL	486	Q9ULD0
HTYCERVALVKLATE	OR52A4P	181	A6NMU1
YRQVVKTDHRQRLQC	PEAR1	76	Q5VY43
TDKYRQLLVRTLHSC	COPB1	376	P53618
TCSIHTNIGLYEKRI	FAM214A	226	Q32MH5
CVFHRGNYVKDLSRL	CTDSP1	181	Q9GZU7
RCSLRLTHYIEEANV	DCAF10	456	Q5QP82
NERSLHYIKRCIEDL	GLYATL1	191	Q969I3
ILRYIARKHNLCGES	GSTM2	76	P28161
QRGFYRVCEKEILRH	HERC6	876	Q8IVU3
ALRTIVKNCYKQHGR	NRF1	261	Q16656
HRQRKYCVVLLTAET	DNAJC16	381	Q9Y2G8
SCHYGVIDKFRLQVS	MOSPD1	86	Q9UJG1
DIVVYHRGSRSCKDA	KANK1	411	Q14678
LSYNQLVERIITCKH	MINDY1	256	Q8N5J2
VRALTYCDLHVIKRD	KCNH1	661	O95259
HAKTNISSYVRLCEV	LPIN1	831	Q14693
GRTIRHVYCKTSDGR	ADAMTSL2	756	Q86TH1
REGSKRYCIQTKHVA	ENPEP	6	Q07075
YSRHRAQTEKHVVLC	KCNT2	291	Q6UVM3
SLAKYRALRCKIEHV	PARP4	371	Q9UKK3
GRVIRDKLRIYAHCT	HPSE2	471	Q8WWQ2
RVYRGIRHTSKFCSI	NIM1K	421	Q8IY84
VTLCKIGYRHVVDAT	EXOSC7	201	Q15024
VCDHYQRILQLRTVT	GARIN1B	156	Q96KD3
AHLTRLCSEYPENKR	IP6K3	181	Q96PC2
TVRLNGCHDRAVLLY	NATD1	31	Q8N6N6
TTKSVSRYRGQEHCL	CXCL14	71	O95715
IRCKSYHLSELVQQI	POLA1	701	P09884
KIIAVLRAHSSYCTD	EXOC6	371	Q8TAG9
QKVHSRKCLVDSREY	PEG3	1126	Q9GZU2
RKCLVDSREYTHSVI	PEG3	1131	Q9GZU2
AVLHSRKLCVYSVSG	BBS9	96	Q3SYG4
GRQHSYLRISLTEKC	MOCS1	66	Q9NZB8
HIKCVRQVRRDNYDA	OTULINL	126	Q9NUU6
KNIHVSDTGRYVCVA	HMCN1	2351	Q96RW7
HYIEARCSIKAIEAA	IFT172	876	Q9UG01
FGCRQSKIDHIYREE	NOS1	1286	P29475
LRVSHGCVSKILCRY	PAX3	76	P23760
GNYRCIAATVAHRRK	PRTG	201	Q2VWP7
ISDVRLQHAGVYVCR	PRTG	291	Q2VWP7
GCKRTYLSQRDLQAH	CBLL1	171	Q75N03
LKASSVYEIHCDRTR	OBSCN	651	Q5VST9
VDGDTKHCVIYRTAT	PIK3R2	661	O00459
TFHKDVVVDLVCYRR	OGDH	496	Q02218
RVSHGCVSKILARYN	PAX1	141	P15863
IESHRTCAYDSLVIR	CUBN	2026	O60494
RLQKKYVAHVSREAC	CNPPD1	76	Q9BV87
CHVGIYDRATREKVV	IGSF21	116	Q96ID5
IVEVQDRKHICPYRT	CPM	331	P14384
REIVSGLKCLHHTYR	ARHGDIG	141	Q99819
CVRALTAIITYHDRE	GPAT4	221	Q86UL3
ARCHRIGQSKAVKVY	CHD6	891	Q8TD26
HKGTYADDCLVQRVT	FCF1	136	Q9Y324
QQYCHEAIREISKLR	PDSS1	381	Q5T2R2
PASAHKIEYSRRRDC	FRS2	401	Q8WU20
SKEILCARATVDHNY	DIPK2A	346	Q8NDZ4
VSYVQLKERCRIEPH	DSP	2181	P15924
KHAGRYTCTAQTIVD	CNTN1	576	Q12860
VRVHACIEKLYNSSG	FHOD3	106	Q2V2M9
RKYSCVILDEAHERT	DHX33	186	Q9H6R0
TNEECQKRYRGHKIT	F11	541	P03951
PLAEEYCRKTIRHTA	ADPRHL1	201	Q8NDY3
DSVRKFICHVVGITY	EIF3K	136	Q9UBQ5
CVEKRAFYRLISGLH	ERO1A	241	Q96HE7
QSDQCLKEHARRIGY	MCCC1	186	Q96RQ3
RAHYRELAAQITKTC	MAN1C1	471	Q9NR34
EARSLRECELYVQKH	PRKAR1A	11	P10644
KIVTCAHRYEARQRV	ITGA7	136	Q13683
HLICQSGDVLRARYE	CLK4	146	Q9HAZ1
TSDVDIIRHCLRTYA	COG2	221	Q14746
IIRHCLRTYATIDKT	COG2	226	Q14746
KLELGFIQYRRERCH	GOLGA8B	436	A8MQT2
ARVCRYIRIVGTHNT	BTBD9	381	Q96Q07
NLVELIYLVSKRCHE	GJB5	201	O95377
CKQVRLQYEHTRSVG	SEC14L6	271	B5MCN3
VDHELGRCTNSVVKY	EHMT1	546	Q9H9B1
FVIETARQLKRAHGC	IRF2BP2	51	Q7Z5L9
VLEHRSYCSAKARDR	CHID1	61	Q9BWS9
QHLCYRNDKVKTDVR	CTNND1	391	O60716
RRKHQIYTGNVTFSC	CNTNAP5	346	Q8WYK1
ESTVCHREREKPITY	FAM153B	26	P0C7A2
LEHRCVESAKIRAKY	GABARAPL2	11	P60520
GVVDIYNCVKALRSR	PTPRK	1106	Q15262
ALAQHKCSRIVRVEY	INSM1	281	Q01101
LFYIHCREVSLVTQR	NLRP3	256	Q96P20
KNITAIAGRDTYIHC	DSCAM	511	O60469
ELGFIQYRRERCHQK	GOLGA8A	466	A7E2F4
RKSERTLECYVHNLL	RRN3	216	Q9NYV6
AVELIRRGLAYVCHQ	QARS1	346	P47897
ELETLKQSSRLVHYC	SZT2	2836	Q5T011
KNATYICQRVKRVSH	HHLA1	501	C9JL84
SVVRRCVKLCTGHEY	CAMK2B	26	Q13554
YDALCILLRHSKNVR	USP9X	2071	Q93008
ICEYTQKSGVSRARH	UTP25	641	Q68CQ4
YESRCCRNTIITFHK	TRIM42	91	Q8IWZ5
KTSRSGYLQRCIIKH	POLR1A	981	O95602
KALIYRIREPQTSHC	RERGL	96	Q9H628
HEEVCAIKIQRAYRR	SCN4A	1726	P35499
RLVETSRCNSHGYIE	THSD7A	1011	Q9UPZ6
CQEVFGRVERYHKKL	SYNE1	8196	Q8NF91
CGVVTIRTVYASHKQ	SYNJ2	186	O15056
LAEKCHRRTVYELEN	FILIP1	171	Q7Z7B0
LSVHVLCRTRLKEYE	HPS3	891	Q969F9
HESSCEYRKVVTRAL	PLCE1	681	Q9P212
VKALQLVYRRHCEAT	RFX2	366	P48378
CISHRTYDIGNRKEF	RGS22	401	Q8NE09
AKQIHAVRYLECSAL	RHOG	146	P84095
YTVCRDLKELRHLAV	ORC5	216	O43913
RNCEHFVTQLRYGKS	PLAAT4	111	Q9UL19
SRTVLHVLGDRTYCK	MPIG6B	116	O95866
ARRYNHETECITFLK	NR1H2	316	P55055
RRGSVHLCCTKVVNY	PRAMEF22	176	A3QJZ6
THENLTYVQLLRRCV	EPPK1	2391	P58107
THENLTYVQLLRRCV	EPPK1	4526	P58107
LRTKCRTYHDVIPIS	RAP1GAP	131	P47736
LVYNTKGCFAVHRIT	RPS4Y2	101	Q8TD47
EGELYCETHARARTK	PDLIM3	336	Q53GG5
CLVQAKDRSYDALVH	REEP1	106	Q9H902
RGLYHLARTEVVCES	MROH2B	1351	Q7Z745
KAFERRLTEYIHCLQ	CNEP1R1	11	Q8N9A8
VCNTPHERLRILYTK	NDUFA5	16	Q16718
RVDYISTRRARQHKC	SVEP1	136	Q4LDE5
RYQHTVRVCGLQKDL	ABCC12	571	Q96J65
RQVLCYELFQSKTRH	CDC42BPA	1336	Q5VT25
SLCTISVDRYVGVRH	ADRA1D	186	P25100
ACRSYSHVVLKEVRF	CHST5	186	Q9GZS9
AREACRSYSHVVLKE	CHST6	161	Q9GZX3
KSCLRHSRTLAEYIR	C12orf56	566	Q8IXR9
AIELSCRGVNAKAYH	RECQL5	276	O94762
TERVYIKHLRDICEG	SPATA13	251	Q96N96
IKHLRDICEGYIRQC	SPATA13	256	Q96N96
DIKALYRRCQALEHL	UNC45B	76	Q8IWX7
YRRCQALEHLGKLDQ	UNC45B	81	Q8IWX7
QEIILRTYARCGHKN	ZNF99	96	A8MXY4
RVYITLDRKICSNHK	TRIM77	286	I1YAP6
KIFTCGSDLRVHQRI	ZFP30	221	Q9Y2G7
GISTVDVTHRYLCRQ	ZFHX2	2441	Q9C0A1
SRQCRETHKIAVFYV	RALGAPA1	1801	Q6GYQ0
LHRCYKSIANLIERR	POLR3C	436	Q9BUI4
YDLDKQTRCVERHIR	RIPOR3	116	Q96MK2
SIACYREIFHERKSQ	TIGD1	526	Q96MW7
CLVDISYSETKRRHV	ARHGAP23	761	Q9P227
LAQVLKRYRDAGLHC	PFAS	961	O15067
KVTFRTRIYHCNINS	UBE2E3	126	Q969T4
KSFRCASYLVIHERI	ZNF607	456	Q96SK3
EHVLRLSRVTENYLC	UNC119B	71	A6NIH7
KVICQYCRRHFVSVT	ZNF292	721	O60281
HYRRECLLKLNEQAA	USP25	926	Q9UHP3
QDVISKGVRLYCRLH	PREX2	476	Q70Z35
ERIEHLCQRISSYKK	PREX2	891	Q70Z35
SHLARVSCRITDLYK	SPTB	66	P11277
LCSLVERISGYVRHR	TMEM168	136	Q9H0V1
YAHKRCEIIDREAIQ	TTC21A	81	Q8NDW8
DSKNYNECIRHETIR	UBE2Z	236	Q9H832
KYELVAVCTVHAGAR	RET	236	P07949
YTKGCTLERNHINVR	ZNF844	631	Q08AG5
VSAAHCYKTRIQVRL	PRSS3	116	P35030
CYKTRIQVRLGEHNI	PRSS3	121	P35030
CTIAHEILAKSLYRQ	TOPAZ1	1461	Q8N9V7
RYRCQRGIVHITSES	ZHX2	491	Q9Y6X8
TSRAACQLVKEYIGH	WDR37	141	Q9Y2I8
HTGKRSYKCREIVRA	ZNF101	191	Q8IZC7
LCDHRLKRQGAQLYV	USP24	801	Q9UPU5
LLSHCKVRETQEYTR	UBR3	586	Q6ZT12
KAFTCPQYVRIHERT	ZNF69	311	Q9UC07
NRLYRDDCTKATHSR	SRY	161	Q05066
RVVLKYRHSDGNLCV	SRP9	26	P49458
CGKVFSRITYLVRHQ	ZNF766	276	Q5HY98
LQEVKRSTYDHTRKC	WDR11	986	Q9BZH6
RSTYDHTRKCTDQLL	WDR11	991	Q9BZH6
LTDPCRNHKSYREVI	RAPGEFL1	551	Q9UHV5
KIQSIYCTDLRVLHQ	TLR4	186	O00206
ITTKHRGLYTCSVRN	PSG5	291	Q15238
YERDCSIQRRHQKVV	PC	261	P11498
QRTGCQLEKRDDLHY	ZNF45	126	Q02386
IEERYKAVCHAARTR	TOE1	81	Q96GM8
RIHTQEKLYECRICG	ZNF181	341	Q2M3W8
HERILTRAKSYECSE	ZNF789	191	Q5FWF6
EVILRTYARCGHKNL	ZNF729	106	A6NN14
CGKVIRESSKYTHIR	ZNF114	366	Q8NC26
FCASRNTDRIHIYTK	ZRANB3	736	Q5FWF4
ERLYHVSISFDRCKI	ZSWIM4	136	Q9H7M6
CSIIVEGRIFKAHRN	ZBTB8B	26	Q8NAP8
RSRVYLHTLAESICK	GUCY1A1	66	Q02108
VIVCLLNHYKVSTRS	LDLRAD4	81	O15165
AIIIQKHCRGYLVRS	MYO5C	811	Q9NQX4
RETRRYHCSGKDQIV	MYO9A	1461	B2RTY4
RGICYLITRHAKDTV	PDE4DIP	1496	Q5VU43
VIHCRYVGDITSDIK	NEB	5076	P20929